MoonLake Immunotherapeutics (MLTX) Retained Earnings (2020 - 2026)

MoonLake Immunotherapeutics' Retained Earnings history runs 7 years deep, the most recent figure standing at $322000.0 for Q1 2026.

• In Q1 2026, Retained Earnings rose 100.12% year-over-year to $322000.0; the TTM figure through Mar 2026 stood at $322000.0 (up 100.12% YoY), while the FY2025 annual figure was $604000.0, down 87.91% from the prior year.
• Retained Earnings was $322000.0 for Q1 2026 at MoonLake Immunotherapeutics, down from $604000.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $5.0 million in Q4 2024 to a low of -$275.5 million in Q1 2025.
• Historically, Retained Earnings has averaged -$40.5 million across 5 years, with a median of $322000.0 in 2026.
• Biggest YoY gain for Retained Earnings was 1072.2% in 2023; the steepest drop was 74727.66% in 2023.
• A 5-year view of Retained Earnings shows it stood at $350946.0 in 2022, then soared by 571.79% to $2.4 million in 2023, then jumped by 111.95% to $5.0 million in 2024, then plunged by 87.91% to $604000.0 in 2025, then slumped by 46.69% to $322000.0 in 2026.
• The last three Retained Earnings figures came in at $322000.0 (Q1 2026), $604000.0 (Q4 2025), and $278000.0 (Q3 2025), per Business Quant data.